Yen Lin Chia,Ute Hoch,Alison Hannah,Michael A. Eldon
申请号：
US14648042
公开号：
US10132810B2
申请日:
2013.11.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided is a method of treating an individual suffering from a cancer such as breast cancer by administering to the individual a long-acting topoisomerase I inhibitor such as SN-38 or irinotecan, and correlating the level of at least one tumor marker such as CA27.29 in the individual with response of the cancer to treatment with the long-acting topoisomerase I inhibitor, to thereby provide a method for predicting and assessing the therapeutic efficacy of the treatment.
